Mountain View, CA, February 24, 2003
IIMPAC Medical
Systems, Inc. (NASDAQ:IMPC), a leading provider of information
solutions for cancer care, today named Gregory T. Schiffman, Vice
President and Chief Financial Officer of Affymetrix Inc., to its
Board of Directors. Mr. Schiffman will also head the audit
committee of IMPAC’s Board.
“Greg’s broad experience as a financial executive, and
particularly his extensive knowledge of the biotechnology and
healthcare industries, will be of immense value to IMPAC as we
continue to grow the Company,” said Joseph K. Jachinowski,
Chairman and Chief Executive Officer. “We are fortunate to have an
individual of Greg’s background and talents join our Board.”
The addition of Mr. Schiffman, age 45, to IMPAC’s Board of
Directors increases its members to seven, with the majority
comprised of independent directors.
Mr. Schiffman joined Affymetrix, a leading pioneer in creating
tools that are driving the genomic revolution, as Vice President,
Finance in March 2001, and five months later was named to his
present position. He previously had been Vice President,
Controller of Applied Biosystems Group, which Mr. Schiffman had
been with since October 1998. Prior to that, he had held various
managerial and financial positions at Hewlett Packard Company and
IBM. .
Mr. Schiffman, a CPA, received a B.S. in accounting from De Paul
University, and an MBA, from Northwestern University’s J.L.
Kellogg Graduate School of Management.
About IMPAC Medical Systems
IMPAC Medical Systems, Inc. is a leading provider of specialized
IT solutions that streamline both clinical and business operations
to help improve the process of delivering quality patient care.
With open integration to multiple healthcare data and imaging
systems, IMPAC offers a comprehensive IT solution that includes
specialized electronic charting, full-featured practice
management, clinical laboratory management, and outcomes
reporting. Supporting over 1500 installations worldwide, IMPAC
delivers practical solutions that deliver better overall
communication, process efficiency and quality patient care. For
more information about IMPAC Medical Systems' products and
services, please call 650-623-8800 or visit
www.impac.com.
The statements contained in this press release that are not
purely historical are forward looking statements within the
meaning of Section 21E of the Securities and Exchange Act of 1934,
including statements regarding the Company's expectations,
beliefs, hopes, intentions or strategies regarding the future.
Forward looking statements include statements regarding the
Company's business strategy, timing of, and plans for, the
introduction of new products and enhancements, future sales,
market growth and direction, competition, market share, revenue
growth, operating margins and profitability. All forward looking
statements included in this document are based upon information
available to the Company as of the date hereof, and the Company
assumes no obligation to update any such forward looking
statement. Actual results could differ materially from the
Company's current expectations. Factors that could cause or
contribute to such differences include the Company's ability to
expand outside the radiation oncology market or expand into
international markets, lost sales or lower sales prices due to
competitive pressures, ability to integrate its products
successfully with related products and systems in the medical
services industry, reliance on distributors and manufacturers of
oncology equipment to market its products, and other factors and
risks discussed in the Company's Final Prospectus dated November
20, 2002 and other reports filed by the Company from time to time
with the Securities and Exchange Commission. |
|
Michelle Arnold
Public Relations Manager
IMPAC Medical Systems, Inc.
650-623-8883
pr@impac.com
|
